1. Trifluoperazine, an Antipsychotic Drug, Effectively Reduces Drug Resistance in Cisplatin-Resistant Urothelial Carcinoma Cells via Suppressing Bcl-xL: An In Vitro and In Vivo Study
   Kuan-Lin Kuo et al, 2019, International Journal of Molecular Sciences CrossRef
2. Repurposing Antipsychotics for Cancer Treatment
   Nikolaos Vlachos et al, 2021, Biomedicines CrossRef
3. Trifluoperazine Synergistically Potentiates Bortezomib-Induced Anti-Cancer Effect in Multiple Myeloma via Inhibiting P38 MAPK/NUPR1
   Zizi Jing et al, 2022, The Tohoku Journal of Experimental Medicine CrossRef